Provided by Tiger Fintech (Singapore) Pte. Ltd.

SILO PHARMA INC.

0.6410
+0.00961.52%
Post-market: 0.6290-0.0120-1.87%19:46 EDT
Volume:110.93K
Turnover:70.40K
Market Cap:4.62M
PE:-0.57
High:0.6448
Open:0.6149
Low:0.6116
Close:0.6314
Loading ...

Silo Pharma, Hoth Therapeutics to Launch Joint Venture for Obesity Treatment

MT Newswires Live
·
25 Jun

Silo Pharma enters into letter of intent to form 50:50 joint venture with Hoth

TIPRANKS
·
25 Jun

Silo Pharma Enters Into Letter of Intent to Form Joint Venture With Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

THOMSON REUTERS
·
25 Jun

BRIEF-Silo Pharma announces Formation Of Joint Venture With Hoth Therapeutics

Reuters
·
25 Jun

Silo Pharma: Formation of Strategic Joint Venture With Hoth Therapeutics

THOMSON REUTERS
·
25 Jun

Silo Pharma: Joint Venture to Develop First-in-Class Gdnf-Based Therapy Licensed From U.S. Dept of Veterans Affairs

THOMSON REUTERS
·
25 Jun

Silo Pharma Inc. Announces USPTO Notice of Allowance for Biomarker Patent on Novel PTSD Therapeutic SPC-15

Reuters
·
11 Jun

Silo Pharma Secures Biomarker Patent for Novel Ptsd Therapeutic Spc-15 as Clinical Trial Nears

THOMSON REUTERS
·
11 Jun

Silo Pharma Inc. Board Approves $1 Million Bitcoin Purchase as Treasury Reserve Asset for Long-Term Value Optimization

Reuters
·
05 Jun

Eric Weisblum, CEO of Silo Pharma Inc., Reports Acquisition of Common Shares

Reuters
·
29 May

Silo Pharma Collaborates With Resyca for Drug-Device Study of PTSD Drug SPC-15

MT Newswires Live
·
21 May

Silo Pharma, Resyca partner for intranasal drug-device study of SPC-15

TIPRANKS
·
21 May

Silo Pharma Partners With Resyca for Ind-Supporting Intranasal Drug-Device Study of Ptsd Drug Spc-15

THOMSON REUTERS
·
21 May

Silo Pharma Initiates Intranasal Drug-Device Study for PTSD Treatment, Partners with Resyca for IND Submission

Reuters
·
21 May

BRIEF-Silo Pharma Announces Closing Of $2 Million Public Offering

Reuters
·
17 May

Silo Pharma Inc. Completes $2 Million Public Offering of Common Stock and Warrants

Reuters
·
17 May

Silo Pharma Announces Closing of $2 Million Public Offering

THOMSON REUTERS
·
17 May

Silo Pharma Announces $2 Million Public Offering of Shares and Warrants

Reuters
·
15 May

Silo Pharma Announces Pricing of $2 Million Public Offering

THOMSON REUTERS
·
15 May

Silo Pharma Engages Veloxity Labs for IND-Enabling Study of Intranasal PTSD Therapy SPC-15

Reuters
·
15 May